QT Imaging Holdings (QTI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Jul, 2026Executive summary
Annual Meeting scheduled for July 28, 2026, to be held virtually; record date is June 23, 2026.
2025 revenue reached $18.9 million, a 288% increase from 2024, with gross margin at 45%.
Net loss for 2025 was $21.1 million, compared to $9.0 million in 2024; net cash used in operations decreased to $9.0 million.
Financial position strengthened by $18.2 million private placement and $5.0 million additional financing; uplisted to Nasdaq in January 2026.
Entered exclusive distribution agreements in Saudi Arabia and UAE for core products.
Voting matters and shareholder proposals
Election of two Class II directors (Bryan Timm and Professor Zeev Weiner) to serve until 2029.
Ratification of BPM LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Approval of amendment to 2024 Equity Incentive Plan to increase shares reserved for issuance by 550,900 to 2,378,178.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of seven members, classified into three classes with staggered three-year terms.
Majority of directors are independent per Nasdaq standards; separation of Chairman and CEO roles.
Board committees: Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and responsibilities.
All directors attended at least 87.5% of meetings in 2025.
Corporate governance guidelines, code of ethics, and insider trading policy in place.
Latest events from QT Imaging Holdings
- H1 revenue rose 116% YoY to $14.0M as scanner shipments doubled to 28.QTI
Shareholder presentation - 2027 reimbursement and SaaS plans underpin a broader hospital growth push.QTI
Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum - Medicare reimbursement and scaling capacity underpin a projected $34.3M FY2026 revenue trajectory.QTI
Investor presentation - Revenue grew 75%; Medicare payment advances, while Gulf delays cut FY26 guidance.QTI
Q3 2026 - Rapid commercial growth and global expansion position the platform for leadership in breast imaging.QTI
IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 - High-resolution, scalable breast imaging platform drives rapid growth and global adoption.QTI
Investor presentation - Q2 2026 revenue jumped 103% to $7.4M, but net loss widened; 2026 outlook reaffirmed.QTI
Q2 2026 - All proposals, including director elections and equity plan amendment, passed by large margins.QTI
AGM 2026 - Q1 2026 revenue rose 133% to $6.5M, with narrowed losses and ongoing risks from customer and region.QTI
Q1 2026